MARATTO

article · Sohag Medical Journal

Study of T cells and natural killer cells expression in patients with immune thrombocytopenic purpura

2024Open accessSohag University

Abstract

immune thrombocytopenic purpura is an autoimmune bleeding disorder characterized by thrombocytopenia owing to increased platelet destruction and decrease platelet production.The hallmark of autoimmune diseases is the breakdown in self-tolerance which characterized by inability of the immune system to distinguish self from nonself-antigens .The abnormalities include increased number of the T helper 1 cells, decreased number or suppress function of regulatory T cells and the platelet destruction by cytotoxicity T lymphocytes.Dysregulated T cells in ITP patients may enable development of platelet autoantibodies, have a direct cytotoxic effect on platelets and inhibit megakaryocytes.Objective: The purpose of this study was to evaluate the percentages of CD4+, CD8+, T helper cells, cytotoxic T cells and NK cells.Patients and Methods: The study included (40) cases of ITP patients and (40) normal healthy participants. Investigations include peripheral blood samples from cases and controls were used to perform CBC, renal function tests, liver function tests,ESR,CD3,CD4,CD8,CD16,CD56,anti-nuclear antibody testing by immunofluorescence and bone marrow examinations only for casesResults and conclusion : Data analysis by using SPSS. A p-value < 0.05 was considered statistically significant. This study show significant decrease in the T helper cell and significant increase in cytotoxic T cells in ITP patients when compared to control people.

Research topics

  • Platelet Disorders and Treatments
  • Blood properties and coagulation
  • Blood groups and transfusion

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/smj.2024.291744.1477

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.